Trulieve Cannabis (CSE: TRUL) has recently announced the opening of four new medical cannabis dispensaries in Florida. Three of these locations are already operational in Miramar Beach, Niceville, and Tampa, with the fourth location in Cocoa set to open this Saturday.

The dispensaries will offer a wide range of popular Trulieve products, including Alchemy, Co2lors, Cultivar Collection, Modern Flower, Momenta, Muse, Roll One, Sweet Talk, and Trekkers. Additionally, customers will have access to partner brands such as Alien Labs, Bellamy Brothers, Binske, Black Tuna, and Sunshine Cannabis exclusively at Trulieve locations in Florida.

CEO Kim Rivers expressed excitement about expanding access to medical cannabis in various regions of Florida with these new dispensaries. Trulieve also provides services such as home delivery, online ordering, and in-store pickup within the state. Veterans receive a 20% discount on every order by showing their military ID, and first-time customers are eligible for a 60% discount at any Florida Trulieve location.

Trulieve is a cannabis company based in Tallahassee, Florida, and operates in multiple states in the US, with strong market positions in Arizona, Florida, and Pennsylvania. As of the latest report, shares of Trulieve Cannabis Corp. have increased by 1.81% to C$11.79.

For additional insights and discussions on this stock, investors can visit the Trulieve Cannabis Corp. Bullboard forum and other stock forums provided by Stockhouse. Please note that the information presented in this article is for informational purposes only and should not be considered as investment advice. Visit the disclaimer page for full disclosure.

(Top photo: Trulieve Cannabis)

Share.

Alexander is the founder and author of Microcaps.ca, a leading resource for investors interested in the micro-cap stock market. With a passion for uncovering hidden gems in the world of small-cap stocks, Alexander combines in-depth research with years of experience in the financial markets to provide readers with valuable insights and timely analysis. Investors should conduct their own research or consult with a qualified investment advisor before making any investment decisions. The author of this article is not responsible for any gains or losses incurred from investing in companies mentioned.

Leave A Reply

Exit mobile version